Brief: Consun Pharmaceutical says unit enters another equity transfer agreement
Nov 9 (Reuters) - Consun Pharmaceutical Group Ltd 1681.HK : * Discloseable transaction further acquisition of 15.42% equity interest in Guangxi Yulin Pharmaceutical Group 1681.HK * Subsidiary has entered into another equity transfer agreement with saiwote * Deal to further acquire 14.36% equity interest in target company at consideration of approximately RMB173 million Source text for Eikon ID:nHKS3nkQdx ((For more news, please click here 1681.HK )) ((Bengaluru Newsroom; +91 80 6749 1130))
Recent news on Consun Pharmaceutical
See all newsChina's Consun Pharmaceutical H1 revenue rises on sales network expansion
Brief: Consun Pharmaceutical Says Unit To Invest RMB191.4 Mln In Shanghai Huamao Pharmaceutical
Brief: Consun Pharmaceutical Group Announces Share Repurchase Program Up To HKD200 Million
Brief: Consun Pharmaceutical Logs FY Revenue RMB 3,420 Mln
Brief: Consun Pharmaceutical Says Executive Director Zhu Quan Redesignated As Non-Executive Director